Table 1.
Baseline patient demographics (n = 36)
| Characteristics | Vaginal cancer (n = 16) | Vulvar cancer (n = 20) |
|---|---|---|
| Median age, years (range) | 60 (30 to 85) | 55 (33 to 78) |
| Race, n (%) | ||
| White | 13 (81 %) | 19 (95 %) |
| Black | 1 (6 %) | 0 |
| Hispanic | 2 (13 %) | 0 |
| Asian | 0 | 1 (5 %) |
| Body Mass Index, n (%) | ||
| Underweight (<18.5) | 0 | 1 (5 %) |
| Normal Weight (18.5 to 25) | 10 (62 %) | 13 (65 %) |
| Overweight (>25) | 6 (38 %) | 6 (30 %) |
| The Eastern Cooperative Oncology Group Performance Status, n (%) | ||
| 0 | 4 (25 %) | 0 |
| 1 | 9 (56 %) | 18 (90 %) |
| 2 | 3 (19 %) | 2 (10 %) |
| Prior Chemotherapy | ||
| Yes, n (%) | 14 (88 %) | 16 (80 %) |
| Median number (range) | 2 (0 to 4) | 1 (0 to 6) |
| Prior Radiation Therapy | ||
| Yes, n (%) | 15 (94 %) | 17 (85 %) |
| Pathological Diagnosis, n (%) | ||
| Squamous Cell Carcinoma | 7 (44 %) | 17 (85 %) |
| Adenocarcinoma | 4 (25 %) | 0 |
| Melanoma | 3 (19 %) | 3 (15 %) |
| Carcinosarcoma | 1 (6 %) | 0 |
| High-grade neuroendocrine carcinoma | 1 (6 %) | 0 |
| Phase I Trial Enrollment, n (%) | 11 (69 %) | 16 (80 %) |